Stocks making the biggest moves in the premarket: Nio, Veru, Sailpoint Technologies and more

Stocks making the biggest moves in the premarket: Nio, Veru, Sailpoint Technologies and more


Take a look at some of the biggest movers in the premarket:

Nio (NIO) – The China-based electric carmaker’s shares slumped 8.4% in premarket action after it suspended production due to Covid-19 related supply chain disruptions.

Veru (VERU) – The drugmaker’s shares surged 24.8% in the premarket after it reported “overwhelming” evidence of efficacy for its experimental drug for treating hospitalized Covid-19 patients. It will meet with the Food and Drug Administration to seek emergency use authorization for the treatment.

Sailpoint Technologies (SAIL) – The cybersecurity company’s shares soared 29.5% in premarket trading after it agreed to be acquired by private-equity firm Thoma Bravo for $6.9 billion or $65.25 per share.

Twitter (TWTR) – Twitter fell 1.5% in the premarket following the announcement that Elon Musk will not be joining Twitter’s board. Musk revealed a 9.2% stake last week, followed by news that he would be joining the board. Neither side gave a reason for the reversal.

Shopify (SHOP) – The e-commerce platform company’s stock added 1.1% in the premarket after it proposed a 10-for-1 stock split, as well as the creation of a new “founder share” that would increase CEO Tobi Lutke’s voting power to 40% from the current 34%.

AT&T (T) – AT&T added 1.9% in the premarket after completing the spin-off of its WarnerMedia unit to Discovery Communications late Friday, with the stock of the newly combined Warner Brothers Discovery (WBD) set to begin trading today under its new name and ticker symbol. Separately, Deutsche Bank named Warner Brothers Discovery a “top pick” given its robust entertainment content.

Nvidia (NVDA) – The graphics chipmaker’s stock slid 3% in premarket action, following the announcement that it would seek shareholder approval to double the number of authorized shares. That would give Nvidia the flexibility to take actions like stock splits and issuing equity incentives without a further shareholder vote.

Lowe’s (LOW) – Lowe’s fell 1% in the premarket after announcing the departure of David Denton as chief financial officer. Denton is leaving the home improvement retailer to take the same job at drugmaker Pfizer (PFE). He’ll be replaced by Senior Vice President Brandon Sink effective April 30.

JetBlue (JBLU) – The airline is cutting back its summer schedule in an effort to avoid flight disruptions, while working to ramp up hiring. JetBlue added 1% in premarket trading.



Source

David Einhorn says the Fed will cut ‘substantially more’ than two times. So he’s betting big on gold
Finance

David Einhorn says the Fed will cut ‘substantially more’ than two times. So he’s betting big on gold

Key Points David Einhorn of Greenlight Capital anticipates the Federal Reserve will cut more than twice in 2026, which is what traders have priced in. Einhorn owns gold and Secured Overnight Financing Rate, or SOFR, futures. Gold has seen massive gains in recent years, though it faced some pressure last month following President Donald Trump’s […]

Read More
Stocks making the biggest moves midday: Acadia Healthcare, Vertiv, Moderna, Unity Software, Generac & more
Finance

Stocks making the biggest moves midday: Acadia Healthcare, Vertiv, Moderna, Unity Software, Generac & more

Check out the companies making headlines in midday trading: Acadia Healthcare — The health-care stock popped 10% after investor David Einhorn told CNBC that he has been buying the stock. The Greenlight Capital fund manager said he’s hopeful the company’s new management will be able to improve its performance. Vertiv — The provider of data […]

Read More
Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more
Finance

Stocks making the biggest moves premarket: Lyft, Moderna, Cloudflare, Ford, Zillow Group and more

Check out the companies making headlines before the bell: Moderna — Shares tumbled 10% after the pharma giant said the Food and Drug Administration refused to review its application for an experimental flu shot, mRNA-1010. Moderna said it has requested a meeting with the FDA to “understand the path forward.” Humana — The health insurance company […]

Read More